Single-dose pharmacokinetics of the direct renin inhibitor aliskiren in healthy Chinese subjects.

被引：0
|
作者：
Bartlett, M. [1 ]
Vaidyanathan, S. [2 ]
Karan, R. S. [2 ]
Hu, P. [3 ]
Howard, D. [4 ]
Yeh, C. M. [4 ]
Dieterich, H. A. [1 ]
Al-Fayoumi, S. [4 ]
Jarugula, V. [4 ]
Doles, W. P. [5 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Healthcare Private Ltd, Hyderabad, Andhra Pradesh, India
[3] Beijing Union Med Coll Hosp, Beijing, Peoples R China
[4] Nova Pharmaceut Corp, E Hanover, NJ USA
[5] Novartis Inst Biomed Res Inc, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2008年 / 83卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [1] Multiple-dose pharmacokinetics of the direct renin inhibitor aliskiren in healthy Chinese subjects.
    Bartlett, M.
    Vaidyanathan, S.
    Karan, R. S.
    Hu, P.
    Howard, D.
    Yeh, C. M.
    Dieterich, H. A.
    Al-Fayoumi, S.
    Jarugula, V.
    Dole, W. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S61 - S62
  • [2] A study of dose-proportionality in the pharmacokinetics of the oral direct renin inhibitor aliskiren in healthy subjects
    Limoges, D.
    Dieterich, H. A.
    Yeh, C. -M.
    Vaidyanathan, S.
    Howard, D.
    Dole, W. P.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2008, 46 (05) : 252 - 258
  • [3] Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects
    Dieterle, W
    Corynen, S
    Mann, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 58 (04) : 433 - 436
  • [4] Effect of aliskiren, an oral direct renin inhibitor, on the pharmacokinetics and pharmacodynamics of a single dose of acenocoumarol in healthy volunteers
    Huang, H. -L. A.
    Vaidyanathan, S.
    Yeh, C. -M.
    BiZot, M. -N.
    Dieterich, H. A.
    Dole, W. P.
    Howard, D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (09) : 2449 - 2456
  • [5] Single-dose pharmacokinetics of levetiracetam in healthy Chinese male subjects
    Zhao, Qian
    Jiang, Ji
    Li, XiaoMing
    Lu, Zhihong
    Hu, Pei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 63 (05) : 614 - 617
  • [6] Pharmacokinetics, safety, and tolerability of the novel oral direct renin inhibitor aliskiren in elderly healthy subjects
    Vaidyanathan, Sujata
    Reynolds, Christine
    Yeh, Ching-Ming
    Bizot, Marie-Noelle
    Dieterich, Hans Armin
    Howard, Dan
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (04): : 453 - 460
  • [7] The pharmacokinetics of the oral direct renin inhibitor aliskiren alone and in combination with the P-glycoprotein modulators ketoconazole, digoxin and atorvastatin in healthy subjects.
    Vaidyanathan, S.
    Reynolds, C.
    Yeh, C.
    Bizot, M.
    Dieterich, H. A.
    Howard, D.
    Dole, W. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S109 - S109
  • [8] Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects
    Chen, Xia
    Hu, Pei
    Vaccaro, Nicole
    Polidori, David
    Curtin, Christopher R.
    Stieltjes, Hans
    Sha, Sue
    Weiner, Sveta
    Devineni, Damayanthi
    CLINICAL THERAPEUTICS, 2015, 37 (07) : 1483 - 1492
  • [9] Aliskiren, an oral direct renin inhibitor, has no effect on the pharmacokinetics or pharmacodynamics of a single dose of acenocoumarol in healthy volunteers.
    Huang, H. A.
    Vaidyanathan, S.
    Yeh, C.
    Dieterich, H. A.
    Dole, W. P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S59 - S60
  • [10] Single-dose pharmacokinetics of methadone in healthy subjects
    Wolff, K
    Hay, AWM
    Shires, S
    Feely, M
    Calvert, R
    RostamiHodjegan, A
    Tucker, GT
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 42 (05) : P670 - P670
12345